Results 241 to 250 of about 176,666 (301)

Proton magnetic resonance spectroscopy with dementia

World Neurosurgery, 1993
To provide new insights into metabolic changes in the brain of patients with dementia, we performed in vivo localized proton magnetic resonance spectroscopy in nine patients with primary degenerative dementia and in three patients with normal-pressure hydrocephalus. We compared the results with those in 26 healthy volunteers.
Akihiko Shiino
exaly   +3 more sources

Proton magnetic resonance spectroscopy

Critical Reviews in Neurosurgery, 1999
Proton magnetic resonance spectroscopy (MRS) permits in vivo determination of biochemical parameters within brain tissue, utilizing the same magnetic resonance (MR) scanner and head coil that are utilized for conventional MR imaging. This technology has been evolving and improving over the past decade, with most of the current published work based on ...
, Zimmerman, , Wang
openaire   +3 more sources

Proton magnetic resonance spectroscopy in schizophrenia

European Journal of Radiology, 1999
Proton magnetic resonance spectroscopy (MRS) has become an important tool to study in vivo certain biochemical aspects of brain disorders. In the last decade this technique has been applied to the in vivo investigation of pathophysiological aspects of psychiatric disorders, extending knowledge of the related brain alterations. This review will focus on
BERTOLINO, Alessandro, DR WEINBERGER
openaire   +2 more sources

Proton magnetic resonance spectroscopy in the fetus

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
Magnetic Resonance Imaging (MRI) has become an established technique in fetal medicine, providing complementary information to ultrasound in studies of the brain. MRI can provide detailed structural information irrespective of the position of the fetal head or maternal habitus.
Story, Lisa, Damodaram, Mellisa S., Allsop, Joanna M., McGuinness, Amy, Wylezinska, Marzena, Kumar, Sailesh, Rutherford, Mary A.   +6 more
openaire   +3 more sources

Proton Magnetic Resonance Spectroscopy in Prostate Tuberculosis

Urology, 2010
Prostate tuberculosis is an uncommon disease of the prostate, which usually involves the upper urinary tract. In the elderly patients, it may be mistaken for prostate carcinoma, both clinically and by conventional radiology. However, magnetic resonance spectroscopy can provide more information to differentiate prostate tuberculosis from prostate cancer.
Yaqing, Chen, Mingjuan, Liu, Yan, Guo
openaire   +2 more sources

Proton magnetic resonance spectroscopy in primary blepharospasm

Neurology, 1998
Single-volume proton magnetic resonance spectroscopy, localized to basal ganglia, was carried out in 10 patients with primary blepharospasm (PB) to assess the levels of N-acetyl aspartate (NAA), creatine-phosphocreatine, and choline-containing compounds. NAA was reduced significantly in patients compared with control subjects.
Federico F, Simone IL, Lucivero V, Defazio G, De Salvia R, Mezzapesa DM, Petruzzellis M, Tortorella C, Livrea P.   +8 more
openaire   +3 more sources

Proton magnetic resonance spectroscopy in frontotemporal dementia

Journal of Neurology, 2006
This study of frontotemporal dementia (FTD) was carried out to determine whether MR spectroscopy can provide an in vivo marker for the neuronal loss and gliosis that occur in this condition. We compared spectra in frontal and temporal regions known to be affected early in the course of the disease with spectra in the parietal lobe that is spared until ...
Coulthard E, Firbank M, English P, Welch J, Birchall D, O'Brien J, Griffiths TD   +6 more
openaire   +3 more sources

Proton magnetic resonance spectroscopy

Journal of Chemical Education, 1988
In this article, the author will demonstrate the interpretation of NMR spectra and use them to determine molecular structures.
openaire   +1 more source

Proton Magnetic Resonance Spectroscopy

2002
Approximately 85%-90% of patients with multiple sclerosis (MS) will begin their disease with a course of relapses and remissions and are therefore classified as having relapsing-remitting (RR) MS [1]. Some of these patients will eventually go on to develop a progressive disability that is characterized by a slow, irreversible deterioration over time ...
Z. Caramanos, A. C. Santos, S. J. Francis, S. Narayanan, D. Pelletier, D. L. Arnold   +5 more
openaire   +1 more source

Proton magnetic resonance spectroscopy findings of hemangioblastoma

Japanese Journal of Radiology, 2010
We report a case of proton magnetic resonance spectroscopy (MRS) of hemangioblastoma in a 56-yearold man with a history of hyperlipidemia who was suffering from an equilibrium disorder. Proton MRS revealed a high mobile lipids (Lip) peak between 0.9 and 1.4 ppm, which was compatible with histologically proven lipids in the tumor.
Tomonori, Isobe, Tetsuya, Yamamoto, Hiroyoshi, Akutsu, Izumi, Anno, Masanari, Shiigai, Alexander, Zaboronok, Tomohiko, Masumoto, Shingo, Takano, Akira, Matsumura   +8 more
openaire   +2 more sources